Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01472614
Recruitment Status : Completed
First Posted : November 16, 2011
Last Update Posted : May 27, 2013
Information provided by (Responsible Party):
Dexa Medica Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : April 2013